ClinicalTrials.govpublic full text
Evaluation of UCPVax Vaccine +/- Pembrolizumab Combined With Standard Treatment as Adjuvant Therapy in Patients With Unmethylated MGMT Glioblastoma
primary glioblastoma, gbm, ucpvax, pembrolizumab, cancer vaccine, telomerase, cd4 t cell, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 897441
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.